Home › Companies › CASTLE BIOSCIENCES INC. › 2024-2025

CASTLE BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CASTLE BIOSCIENCES INC.’s Form 8-K, filed 2025-05-23 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 7Ballot items
  • 217Asset managers
  • 1,384Fund votes
  • 2025-05-22Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CASTLE BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CASTLE BIOSCIENCES INC.

These tallies are CASTLE BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CASTLE BIOSCIENCES INC. — official shareholder meeting results, meeting held 2025-05-22
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Kimberlee S. Caple 13,580,035---- 7,764,1452,358,393 Majority: yes
Elect Director: G. Bradley Cole 19,839,019---- 1,505,1612,385,393 Majority: yes
Elect Director: Derek J. Maetzold 19,909,583---- 1,434,5972,385,393 Majority: yes
Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection of KPMG LLP by the Audit Committee of the Company's Board of Directors as the Company's independent 23,690,09820,83718,638 ---- Majority: yes
Proposal 3. Approval of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Sta 19,986,7681,314,25443,158 --2,385,393 Majority: yes
Proposal 4. Approval of Amendment and Restatement of the Company's Amended and Restated Certificate of Incorporation. 20,327,249976,00040,931 --2,385,393 Majority: yes

Source: CASTLE BIOSCIENCES INC., Form 8-K, filed with the SEC on 2025-05-23 — read the filing on EDGAR.

How asset managers voted at the CASTLE BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 217 asset managers that disclosed a CASTLE BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 12 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 19,986,768AGAINST: 1,314,254

CASTLE BIOSCIENCES INC.’s own tally for this item (“Proposal 3. Approval of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the”): 19,986,768 for, 1,314,254 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,844,937 outstanding shares: 69% for, 5% against (74% of the company cast a for/against vote).

The 215 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 97%
FOR: 96.6%AGAINST: 3.3%ABSTAIN: 0.1%
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy ” at CASTLE BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,762,7280 00For
Vanguard2,071,3290 00For
Portolan Capital Management, LLC1,222,7230 00For
Dimensional1,165,3590 00For
Fidelity1,140,3720 00For
Nuveen1,047,6590 00For
WASATCH ADVISORS LP997,8930 00For
WASATCH FUNDS TRUST943,7150 00For
PRINCIPAL GLOBAL INVESTORS911,6780 00For
State Street710,2300 00For
TIAA691,2910 00For
GEODE CAPITAL MANAGEMENT, LLC649,7530 00For
Wellington640,9240 00For
Principal622,3000 00For
SCHRODER INVESTMENT MANAGEMENT GROUP561,6530 00For
Park West Asset Management LLC556,4850 00For
Charles Schwab484,5130 00For
Renaissance402,8310 00For
Allianz431392,643 00Against
BRAIDWELL LP365,2470 00For
Point72361,4170 00For
PALISADE CAPITAL MANAGEMENT, LP307,5800 00For
BUFFALO FUNDS278,3140 00For
Allspring270,8700 00For
Columbia Threadneedle258,6810 00For

Showing the 25 largest of 215 asset managers. See all 215 in the interactive database.

2. To approve the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company to the maximum extent permitted by Delaware law.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 20,327,249AGAINST: 976,000

CASTLE BIOSCIENCES INC.’s own tally for this item (“Proposal 4. Approval of Amendment and Restatement of the Company's Amended and Restated Certificate of Incorporation.”): 20,327,249 for, 976,000 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,844,937 outstanding shares: 70% for, 3% against (74% of the company cast a for/against vote).

The 68 asset managers below cast 98% of the shares they voted on this item FOR (9,996,818 for, 181,309 against).

FOR 98%
FOR: 9,996,818 (98.0%)AGAINST: 181,309 (1.8%)ABSTAIN: 26,063 (0.3%)
Largest asset managers voting on “To approve the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to” at CASTLE BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,010,0320 00For
BlackRock1,512,3630 00For
Fidelity1,139,2520 00For
Dimensional1,041,8880 00For
WASATCH FUNDS TRUST943,7150 00For
TIAA691,2910 00For
Principal622,3000 00For
BUFFALO FUNDS278,3140 00For
Columbia Threadneedle258,6810 00For
Charles Schwab242,2550 00For
Allspring159,6950 00For
Nuveen156,2140 00For
State Street121,16830 00For
SHELTON CAPITAL MANAGEMENT114,0080 00For
SEI082,675 00Against
Equitable79,3330 00For
American Century73,9540 00For
Hartford65,4090 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC49,1000 00For
Exchange Place Advisors Trust048,810 00Against
QUANTITATIVE MASTER SERIES LLC44,7340 00For
CLEARWATER INVESTMENT TRUST42,5110 00For
Putnam41,9770 00For
Lincoln Financial38,3350 00For
Goldman Sachs34,9640 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

3. To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 23,690,098AGAINST: 20,837

CASTLE BIOSCIENCES INC.’s own tally for this item (“Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection of KPMG LLP by the Audit Committee of the Company's Board of Directors as the C”): 23,690,098 for, 20,837 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,844,937 outstanding shares: 82% for, 0.1% against (82% of the company cast a for/against vote).

The 68 asset managers below cast 99.9% of the shares they voted on this item FOR (10,198,792 for, 335 against).

FOR 99.9%
FOR: 10,198,792 (99.9%)AGAINST: 335 (0.0%)ABSTAIN: 5,063 (0.0%)
Largest asset managers voting on “To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent regist” at CASTLE BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,010,0320 00For
BlackRock1,512,3630 00For
Fidelity1,139,2520 00For
Dimensional1,041,8880 00For
WASATCH FUNDS TRUST943,7150 00For
TIAA691,2910 00For
Principal622,3000 00For
BUFFALO FUNDS278,3140 00For
Columbia Threadneedle258,6810 00For
Charles Schwab242,2550 00For
Allspring159,6950 00For
Nuveen156,2140 00For
State Street121,1980 00For
SHELTON CAPITAL MANAGEMENT114,0080 00For
SEI82,6750 00For
Equitable79,3330 00For
American Century73,9540 00For
Hartford65,4090 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC49,1000 00For
Exchange Place Advisors Trust48,8100 00For
QUANTITATIVE MASTER SERIES LLC44,7340 00For
CLEARWATER INVESTMENT TRUST42,5110 00For
Putnam41,9770 00For
Lincoln Financial38,3350 00For
Goldman Sachs34,9640 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

4. To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: Kimberlee S. Caple

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 6 wordings of this item as funds reported it.

64% Majority: yes · of votes cast

FOR 64%WITHHELD 36%
FOR: 13,580,035WITHHELD: 7,764,145

CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: Kimberlee S. Caple”): 13,580,035 for, 7,764,145 withheld, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,844,937 outstanding shares: 47.1% for, 27% withheld (74% of the company cast a for/withheld vote).

The 67 asset managers below cast 100% of the shares they voted on this item FOR (7,286,182 for, 0 against).

FOR 71%ABSTAIN 29%
FOR: 7,286,182 (71.4%)ABSTAIN: 2,915,566 (28.6%)
Largest asset managers voting on “To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholde” at CASTLE BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,000,2080 9,8240For
BlackRock1,512,3630 00For
Fidelity588,0520 551,2000For
Dimensional00 1,041,8880Abstain
WASATCH FUNDS TRUST943,7150 00For
TIAA691,2910 00For
Principal00 622,3000Abstain
BUFFALO FUNDS278,3140 00For
Columbia Threadneedle258,6810 00For
Charles Schwab242,2550 00For
Allspring00 159,6950Abstain
Nuveen156,2140 00For
State Street121,0220 1760For
SHELTON CAPITAL MANAGEMENT00 114,0080Abstain
SEI82,6750 00For
Equitable45,9630 33,3700For
American Century00 73,9540Abstain
Hartford65,4090 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC00 49,1000Abstain
Exchange Place Advisors Trust48,8100 00For
QUANTITATIVE MASTER SERIES LLC44,7340 00For
CLEARWATER INVESTMENT TRUST00 42,5110Abstain
Putnam41,9770 00For
Lincoln Financial19,2000 19,1350For
Goldman Sachs00 34,9640Abstain

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

5. To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: G. Bradley Cole

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 6 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%
FOR: 19,839,019WITHHELD: 1,505,161

CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: G. Bradley Cole”): 19,839,019 for, 1,505,161 withheld, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,844,937 outstanding shares: 69% for, 5% withheld (74% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (9,092,165 for, 0 against).

FOR 89%11%
FOR: 9,092,165 (89.2%)ABSTAIN: 1,097,180 (10.8%)
Largest asset managers voting on “To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholde” at CASTLE BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,010,0320 00For
BlackRock1,512,3630 00For
Fidelity1,139,2520 00For
Dimensional00 1,041,8880Abstain
WASATCH FUNDS TRUST943,7150 00For
TIAA691,2910 00For
Principal622,3000 00For
BUFFALO FUNDS278,3140 00For
Columbia Threadneedle258,6810 00For
Charles Schwab242,2550 00For
Allspring159,6950 00For
Nuveen156,2140 00For
State Street121,1980 00For
SHELTON CAPITAL MANAGEMENT114,0080 00For
Equitable54,5600 33,3700For
SEI82,6750 00For
American Century73,9540 00For
Hartford65,4090 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC49,1000 00For
Exchange Place Advisors Trust48,8100 00For
QUANTITATIVE MASTER SERIES LLC44,7340 00For
CLEARWATER INVESTMENT TRUST42,5110 00For
Putnam41,9770 00For
Lincoln Financial35,7350 2,6000For
Goldman Sachs34,9640 00For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

6. DIRECTOR: DEREK MAETZOLD

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-22.

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 19,909,583WITHHELD: 1,434,597

CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: Derek J. Maetzold”): 19,909,583 for, 1,434,597 withheld, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,844,937 outstanding shares: 69% for, 5% withheld (74% of the company cast a for/withheld vote).

The 26 asset managers below cast 100% of the shares they voted on this item FOR (2,386,880 for, 0 against).

FOR 99.4%
FOR: 2,386,880 (99.4%)ABSTAIN: 13,280 (0.6%)
Largest asset managers voting on “DIRECTOR: DEREK MAETZOLD” at CASTLE BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,512,3630 00For
BUFFALO FUNDS278,3140 00For
Charles Schwab242,2550 00For
SEI82,6750 00For
Hartford65,4090 00For
Exchange Place Advisors Trust48,8100 00For
QUANTITATIVE MASTER SERIES LLC44,7340 00For
Northern Lights Fund Trust IV17,1530 00For
MASTER INVESTMENT PORTFOLIO16,7780 00For
Harbor ETF Trust16,5950 00For
Global X15,4410 00For
JPMorgan15,2750 00For
John Hancock9,2150 1,1790For
Bridge Builder Trust9,5840 00For
RBC FUNDS TRUST8,3000 00For
Jackson National00 6,6070Abstain
Brighthouse00 5,0630Abstain
NORTHERN LIGHTS FUND TRUST II1,0250 00For
Nationwide1,0240 00For
NEW COVENANT FUNDS7300 00For
Texas Capital Funds Trust6940 00For
Allianz00 4310Abstain
Innovator ETFs Trust2240 00For
WILSHIRE MUTUAL FUNDS INC1710 00For
Advisors' Inner Circle Fund III1110 00For

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

7. To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-23 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

99% Majority: yes · of votes cast

FOR 99%
FOR: 20,622,511AGAINST: 306,249

CASTLE BIOSCIENCES INC.’s own tally for this item (“Proposal 3. Approval of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the”): 20,622,511 for, 306,249 against, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,844,937 outstanding shares: 71% for, 1% against (73% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 81 against).

AGAINST 100%
AGAINST: 81 (100.0%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy ” at CASTLE BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC081 00Against
Echo45 Advisors LLC00 00--

Largest CASTLE BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked by the number of CASTLE BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 28,844,937 shares outstanding at the time of that meeting.

Top CASTLE BIOSCIENCES INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 9.58%
2Vanguard 7.18%
3Portolan Capital Management, LLC 4.24%
4Dimensional 4.04%
5Fidelity 3.95%
6Nuveen 3.63%
7WASATCH ADVISORS LP 3.46%
8WASATCH FUNDS TRUST 3.27%
9PRINCIPAL GLOBAL INVESTORS 3.16%
10State Street 2.46%

Reported CASTLE BIOSCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CASTLE BIOSCIENCES INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 10.34% 13F
RTW Investments, LP 9.56% 13G
Vanguard Group 7.10% 13F
Wasatch Advisors, LP. 6.23% DEF14A
Principal Financial Group, Inc. 4.98% DEF14A
Dimensional Fund Advisors LP 3.97% 13G
Derek J. Maetzold 3.12% DEF14A
Wellington Management 2.87% 13F
State Street 2.48% 13F
Renaissance Technologies 2.43% 13F

Percentages above are of 28,844,937 shares outstanding, as reported by CASTLE BIOSCIENCES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CASTLE BIOSCIENCES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CASTLE BIOSCIENCES INC.'s shareholder meeting held 2025-05-22, in the 2024-2025 proxy season, 217 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 1,384 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers, as… — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CASTLE BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-23.

CASTLE BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.